STOCK TITAN
  1. Home
  2. Sec-filings
  3. INBP
  4. [Form 4] INTEGRATED BIOPHARMA INC Insider Trading Activity

INTEGRATED BIOPHARMA (INBP) insider entities gift 1.36M shares to CDDS 2.0 LLC

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

INTEGRATED BIOPHARMA INC insider reporting reflects non-market gifts of Common Stock by entities associated with the late Carl DeSantis. CD Financial, LLC transferred 1,356,293 shares and the Carl DeSantis Revocable Trust transferred 7,392 shares to CDDS 2.0, LLC, a Florida LLC controlled by Damon DeSantis. After these bona fide gifts, a total of 11,366,673 shares of Common Stock remain indirectly held through CD Financial, LLC, the revocable trust and the Estate of Carl DeSantis.

Positive

  • None.

Negative

  • None.
Insider DESANTIS CARL
Role 10% Owner
Type Security Shares Price Value
Gift Common Stock 1,356,293 $0.00 --
Gift Common Stock 7,392 $0.00 --
Holdings After Transaction: Common Stock — 11,374,065 shares (Indirect, Reporting Person is deceased)
Footnotes (1)
  1. Represents 1,356,293 shares of Common Stock transferred from CD Financial, LLC, a Florida limited liability company, to CDDS 2.0, LLC, a Florida limited liability company controlled by Damon DeSantis. Includes 9,116,547 shares of Common Stock owned by CD Financial, LLC, 2,242,809 shares of Common Stock owned by the Carl DeSantis Revocable Trust and 14,709 shares of Common Stock owned by the Estate of Carl DeSantis. Represents 7,392 shares of Common Stock transferred from the Carl DeSantis Revocable Trust to CDDS 2.0, LLC, a Florida limited liability company controlled by Damon DeSantis. Includes 9,116,547 shares of Common Stock owned by CD Financial, LLC, 2,235,417 shares of Common Stock owned by the Carl DeSantis Revocable Trust and 14,709 shares of Common Stock owned by the Estate of Carl DeSantis.
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
DESANTIS CARL
(Last)(First)(Middle)
C/O CDS INTERNATIONAL HOLDINGS
3299 NW SECOND AVE
(Street)
BOCA RATON FLORIDA 33431
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
INTEGRATED BIOPHARMA INC [ INBP ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
DirectorX10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
03/24/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock03/24/2026G1,356,293(1)D$011,374,065(2)IReporting Person is deceased
Common Stock03/24/2026G7,392(3)D$011,366,673(4)IReporting Person is deceased
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Represents 1,356,293 shares of Common Stock transferred from CD Financial, LLC, a Florida limited liability company, to CDDS 2.0, LLC, a Florida limited liability company controlled by Damon DeSantis.
2. Includes 9,116,547 shares of Common Stock owned by CD Financial, LLC, 2,242,809 shares of Common Stock owned by the Carl DeSantis Revocable Trust and 14,709 shares of Common Stock owned by the Estate of Carl DeSantis.
3. Represents 7,392 shares of Common Stock transferred from the Carl DeSantis Revocable Trust to CDDS 2.0, LLC, a Florida limited liability company controlled by Damon DeSantis.
4. Includes 9,116,547 shares of Common Stock owned by CD Financial, LLC, 2,235,417 shares of Common Stock owned by the Carl DeSantis Revocable Trust and 14,709 shares of Common Stock owned by the Estate of Carl DeSantis.
/s/ William H Milmoe, Personal Representative03/26/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider activity did INBP report for Carl DeSantis on this Form 4?

The filing shows non-market gift transfers of INBP Common Stock by entities associated with the late Carl DeSantis, rather than open-market buying or selling, indicating ownership is being reallocated within related entities.

How many INBP shares were transferred as gifts in this filing?

Entities tied to Carl DeSantis made bona fide gifts of 1,363,685 shares of INBP Common Stock in total, combining 1,356,293 shares from CD Financial, LLC and 7,392 shares from the Carl DeSantis Revocable Trust.

Who received the gifted INBP shares disclosed in the Form 4?

The gifted INBP shares were transferred to CDDS 2.0, LLC, a Florida limited liability company controlled by Damon DeSantis, consolidating part of the family’s holdings in that entity according to the footnotes.

How many INBP shares remain indirectly held after these transactions?

Following the gifts, 11,366,673 INBP shares remain indirectly held. These are owned through CD Financial, LLC, the Carl DeSantis Revocable Trust and the Estate of Carl DeSantis, as detailed in the ownership footnotes.

Does the INBP Form 4 show any open-market insider buying or selling?

No. The INBP Form 4 reports bona fide gift transactions, not open-market purchases or sales. The transfers reflect internal reallocation of ownership among related entities rather than trading in the public market.